On February 12, 2025, CME Group Inc (CME, Financial) released its 8-K filing reporting a remarkable financial performance for the fourth quarter and full year of 2024. The company achieved record annual revenue, adjusted operating income, adjusted net income, and adjusted earnings per share, marking a significant milestone in its financial history.
Based in Chicago, CME Group Inc (CME, Financial) operates as a leading derivatives marketplace, offering a wide range of global benchmark products across various asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company has expanded its reach through strategic acquisitions and partnerships, including a 27% stake in S&P Dow Jones Indices.
For the fourth quarter of 2024, CME Group Inc (CME, Financial) reported revenue of $1.5 billion, slightly below the analyst estimate of $1.51878 billion. However, the company's diluted earnings per share (EPS) of $2.40 exceeded the estimated EPS of $2.38. On an adjusted basis, the EPS was $2.52, further surpassing expectations. The company's performance was driven by volume growth across all asset classes, setting new records in interest rates, agricultural, foreign exchange, and metals markets.
CME Group Inc (CME, Financial) reported a record annual revenue of $6.1 billion for 2024, a 10% increase from the previous year, slightly below the annual revenue estimate of $6.11489 billion. The company's net income for the year was $3.5 billion, with a diluted EPS of $9.67, slightly above the estimated annual EPS of $9.64. On an adjusted basis, the net income was $3.7 billion, and the diluted EPS was $10.26.
The company's clearing and transaction fees revenue for the fourth quarter totaled $1.2 billion, with a total average rate per contract of $0.701. Market data revenue reached $182 million. As of December 31, 2024, CME Group Inc (CME, Financial) held approximately $3.1 billion in cash and $3.4 billion in debt. The company declared dividends totaling $3.8 billion during 2024, including a significant annual variable dividend of $2.1 billion.
In 2024, CME Group had its best year ever, generating record annual average daily volume, revenue, adjusted operating income, adjusted net income, and adjusted earnings per share," said Terry Duffy, CME Group Chairman and Chief Executive Officer.
CME Group Inc (CME, Financial)'s strong financial performance underscores its ability to capitalize on market opportunities and manage risks effectively. The company's strategic focus on expanding its product offerings and enhancing its technological capabilities has positioned it well in the competitive capital markets industry. Despite economic and geopolitical uncertainties, CME Group Inc (CME) remains committed to serving its global clients and pursuing growth opportunities.
| Metric | Q4 2024 | Full Year 2024 |
|---|---|---|
| Revenue | $1.5 billion | $6.1 billion |
| Net Income | $875 million | $3.5 billion |
| Diluted EPS | $2.40 | $9.67 |
| Adjusted Net Income | $919 million | $3.7 billion |
| Adjusted Diluted EPS | $2.52 | $10.26 |
For more detailed insights and analysis, visit the full earnings report on the SEC website.
Explore the complete 8-K earnings release (here) from CME Group Inc for further details.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。